Skip to main content

The PSNet Collection: All Content

The AHRQ PSNet Collection comprises an extensive selection of resources relevant to the patient safety community. These resources come in a variety of formats, including literature, research, tools, and Web sites. Resources are identified using the National Library of Medicine’s Medline database, various news and content aggregators, and the expertise of the AHRQ PSNet editorial and technical teams.

Search All Content

Search Tips
Selection
Format
Download
Filter By Author(s)
Advanced Filtering Mode
Date Ranges
Published Date
Original Publication Date
Original Publication Date
PSNet Publication Date
Additional Filters
Origin/Sponsor
Selection
Format
Download
Displaying 1 - 5 of 5 Results
Mackenhauer J, Winsløv J-H, Holmskov J, et al. Crisis. 2021;43:307-314.
Prior research has found that patients who die by suicide often had recent contact with the healthcare setting. Based on a multi-year chart review at one institution, the authors concluded that suicide risk assessment and documentation in the heath record to be insufficient. The authors outline quality improvement recommendations focused on improving documentation, suicide assessment and intervention training, and improving communications with families, caregivers, and other health care providers.
Kristensen S, Christensen KB, Jaquet A, et al. BMJ Open. 2016;6:e010180.
A leadership training intervention targeting clinical managers at a Danish psychiatric hospital was associated with a significant improvement in staff perceptions of safety culture. A Patient Safety Primer discusses the role of organizational leadership in promoting patient safety.
Saedder EA, Brock B, Nielsen LP, et al. Eur J Clin Pharmacol. 2014;70:637-45.
This systematic review identified seven medication classes associated with the most severe medication errors: methotrexate, warfarin, nonsteroidal anti-inflammatory drugs, digoxin, opioids, aspirin, and beta-blockers. The authors suggest that focusing on these medication classes will reduce morbidity and mortality due to adverse drug events, a departure from the commonly advocated universal medication safety recommendations.